14-day Premium Trial Subscription Try For FreeTry Free
Bruker's (BRKR) recent buyout strengthens the company as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies.

Here's Why You Should Add Bruker (BRKR) Stock to Your Kitty

01:52pm, Monday, 04'th Apr 2022 Zacks Investment Research
Bruker's (BRKR) Nano Group microelectronics and semiconductor metrology tools continue to perform well on ongoing strength in bookings and backlog.
Bruker's (BRKR) Nano Group microelectronics and semiconductor metrology tools continue to perform well on ongoing strength in bookings and backlog.

Does Bruker (BRKR) Have the Potential to Rally 33% as Wall Street Analysts Expect?

03:00pm, Monday, 07'th Mar 2022 Zacks Investment Research
The consensus price target hints at a 33.5% upside potential for Bruker (BRKR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r
The consensus price target hints at a 33.5% upside potential for Bruker (BRKR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate r

Bruker (BRKR) to Improve Spatial Biology With New Launch

03:02pm, Friday, 04'th Mar 2022 Zacks Investment Research
Bruker's (BRKR) acquired company, Canopy Biosciences, introduced its next generation of ChipCytometry instrumentation for spatial biology.
Biotech company Canopy Biosciences (BRKR) on Friday announced the launch of its Chip Cytometry instrument called CellSpace system. ChipCytometry delivers single-cell targeted…
Bruker's (BRKR) acquired company, Canopy Biosciences, introduced its next generation of ChipCytometry instrumentation for spatial biology.

Bruker (BRKR), Newomics to Co-Market Joint MnESI-MS Platform

02:18pm, Thursday, 03'rd Mar 2022 Zacks Investment Research
The maxis II and timsTOF Pro 2 mass spectrometers from Bruker (BRKR) will be marketed with Newomics's MnESI product line.

Here's Why You Should Invest In Bruker (BRKR) Stock Now

02:17pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
Investors are optimistic about Bruker's (BRKR) better-than-expected revenues and robust segmental performance.
Investors are optimistic about Bruker's (BRKR) better-than-expected revenues and robust segmental performance.
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in Cowen's 42nd Annual Health Care Conference which is taking place virtually o

For Big Money, Bruker Corporation Passes Test

12:32pm, Tuesday, 22'nd Feb 2022 FX Empire
Bruker Corporation (BRKR) stock has jumped over the past month, gaining 3.6%. And the scientific instrument company could rise even more due to growing demand. But another likely reason is Big Money lifting the stock.

Bruker raises dividend by 25% to $0.05/share

12:16pm, Friday, 18'th Feb 2022 Seeking Alpha
Bruker (BRKR) declares $0.05/share quarterly dividend, 25% increase from prior dividend of $0.04.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE